Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 22, 2011 - Issue 5
Submit an article Journal homepage
345
Views
41
CrossRef citations to date
0
Altmetric
Treatment

Pyoderma gangrenosum: Study of 21 patients and proposal of a ‘clinicotherapeutic’ classification

Angelo Valerio MarzanoDermatology Unit – Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano – Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, Milan, Italy
,
Valentina TrevisanDermatology Unit – Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano – Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, Milan, ItalyCorrespondence[email protected]
,
Riccardo LazzariDermatology Unit – Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano – Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, Milan, Italy
&
Carlo CrostiDermatology Unit – Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano – Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, Milan, Italy
Pages 254-260 | Received 15 Dec 2009, Accepted 05 Feb 2010, Published online: 28 Jul 2010

References

  • Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: A review of 86 patients. Q J Med. 1985;55(217):173–186.
  • Von den Driesch P. Pyoderma gangrenosum: A report of 44 cases with follow-up. Br J Dermatol. 1997;137(6):1000–1005.
  • Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79(1):37–46.
  • Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol. 1989;125(1):57–64.
  • Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: Clinical and therapeutic features. J Dermatolog Treat. 2004;15(3):146–152.
  • Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: A review. J Cutan Pathol. 2003;30(2):97–107.
  • Lee MR, Cooper AJ. Mycophenolate mofetil in pyoderma gangrenosum. J Dermatolog Treat. 2004;15(5):303–307.
  • Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–509.
  • Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol. 2005;32(3):199–203.
  • Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat. 2001;12(1):13–17.
  • Marzano AV, Trevisan V, Lazzari R, Crosti C. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum. J Dermatolog Treat. 2009 Oct 5. [Epub ahead of print].
  • Marzano AV, Tourlaki A, Alessi E, Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: A 10-year history with a recent response to infliximab. Clin Exp Dermatol. 2008;33(2):156–159.
  • Marzano AV, Trevisan V, Galloni C, Alessi E. Fatal bullous pyoderma gangrenosum in a patient with Klinefelter's syndrome. Acta Derm Venereol. 2008;88(2):158–159.
  • Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53(2):273–283.
  • Griffiths CE, Katsambas A, Dijkmans BA, Finlay AY, Ho VC, Johnston A, Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol. 2006;155(suppl 2):1–16.
  • Madan V, Griffiths CE. Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther. 2007;20(4):239–250.
  • Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003;98(8):1821–1826.
  • Kaur MR, Lewis HM. Severe recalcitrant pyoderma gangrenosum treated with infliximab. Br J Dermatol. 2005;153(3):689–691.
  • Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: An update on its dermatologic aspects. Lupus. 2009;18(11):935–940.
  • Eaton PA, Callen JP. Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol. 2009;145(7):781–785.
  • Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol. 2007;157(6):1235–1239.
  • Freedman AM, Phelps RG, Lebwohl M. Pyoderma gangrenosum associated with anticardiolipin antibodies in a pregnant patient. Int J Dermatol. 1997;36(3):205–207.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.